Annual Report & Accounts 2026
75
OUR FINANCIALS
26. FINANCIAL INSTRUMENTS
In common with other businesses, the Group is exposed to risks that arise from its use of financial instruments. This note describes the Group’s objectives, policies and processes for managing those risks and the methods used to measure them. Further quantitative information in respect of these risks is presented throughout these financial statements.
The significant accounting policies regarding financial instruments are disclosed in note 2.
There have been no substantive changes in the Group’s exposure to financial instrument risks, its objectives, policies and processes for managing those risks or the methods used to measure them from previous years, unless otherwise stated in this note.
The principal financial instruments used by the Group, from which financial instrument risk arises, are as follows:
FINANCIAL ASSETS
INVESTMENTS
Company
Group
2026 £ 2026 £ 2026 £ 2026 £ Investments held at FVTPL
–
–
313,738
129,350
FINANCIAL ASSETS AT AMORTISED COST
Company
Group
2026 £ 2026 £ 2026 £ 2026 £ Cash and cash equivalents
–
–
9,744,084
9,687,172
Trade and other receivables
11,026,548
12,598,826
30,828,556
26,447,874
11,026,548
12,598,826
40,572,640
36,135,046
The fair values of the financial assets are not materially different to their carrying values due to the short-term nature of the current assets. Impairment losses on trade receivables and accrued income disclosed in note 17 represent the only impairment gains or losses on financial instruments during the year.
OUR FINANCIALS
26. FINANCIAL INSTRUMENTS
In common with other businesses, the Group is exposed to risks that arise from its use of financial instruments. This note describes the Group’s objectives, policies and processes for managing those risks and the methods used to measure them. Further quantitative information in respect of these risks is presented throughout these financial statements.
The significant accounting policies regarding financial instruments are disclosed in note 2.
There have been no substantive changes in the Group’s exposure to financial instrument risks, its objectives, policies and processes for managing those risks or the methods used to measure them from previous years, unless otherwise stated in this note.
The principal financial instruments used by the Group, from which financial instrument risk arises, are as follows:
FINANCIAL ASSETS
INVESTMENTS
Company
Group
2026 £ 2026 £ 2026 £ 2026 £ Investments held at FVTPL
–
–
313,738
129,350
FINANCIAL ASSETS AT AMORTISED COST
Company
Group
2026 £ 2026 £ 2026 £ 2026 £ Cash and cash equivalents
–
–
9,744,084
9,687,172
Trade and other receivables
11,026,548
12,598,826
30,828,556
26,447,874
11,026,548
12,598,826
40,572,640
36,135,046
The fair values of the financial assets are not materially different to their carrying values due to the short-term nature of the current assets. Impairment losses on trade receivables and accrued income disclosed in note 17 represent the only impairment gains or losses on financial instruments during the year.